Hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: a prospective randomized controlled trial
Abstract Background Hypoxic preconditioning (HPC) may protect multiple organs from various injuries. We hypothesized that HPC would reduce lung injury in patients undergoing thoracoscopic lobectomy. Methods In a prospective randomized controlled trial, 70 patients undergoing elective thoracoscopic l...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Anesthesiology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12871-019-0854-z |
_version_ | 1818408102303629312 |
---|---|
author | Wenjing Zhang Mo Chen Hongbin Li Jia Yuan Jingjing Li Feixiang Wu Yan Zhang |
author_facet | Wenjing Zhang Mo Chen Hongbin Li Jia Yuan Jingjing Li Feixiang Wu Yan Zhang |
author_sort | Wenjing Zhang |
collection | DOAJ |
description | Abstract Background Hypoxic preconditioning (HPC) may protect multiple organs from various injuries. We hypothesized that HPC would reduce lung injury in patients undergoing thoracoscopic lobectomy. Methods In a prospective randomized controlled trial, 70 patients undergoing elective thoracoscopic lobectomy were randomly allocated to the HPC group or the control group. Three cycles of 5-min hypoxia and 3-min ventilation applied to the nondependent lung served as the HPC intervention. The primary outcome was the PaO2/FiO2 ratio. Secondary outcomes included postoperative pulmonary complications, pulmonary function, and duration of hospital stay. Results HPC significantly increased the PaO2/FiO2 ratio compared with the control at 30 min after one-lung ventilation and 7 days after operation. Compared with the control, it also significantly improved postoperative pulmonary function and markedly reduced the postoperative hospital stay duration. No significant differences between groups were observed in the incidence of pulmonary complications or overall postoperative morbidity. Conclusions HPC improves postoperative oxygenation, enhances the recovery of pulmonary function, and reduces the duration of hospital stay in patients undergoing thoracoscopic lobectomy. Trial registration This study was registered in the Chinese Clinical Trial Registry (ChiCTR-IPR-17011249) on April 27, 2017. |
first_indexed | 2024-12-14T09:38:23Z |
format | Article |
id | doaj.art-d6f64910b1174cd4a849565245044377 |
institution | Directory Open Access Journal |
issn | 1471-2253 |
language | English |
last_indexed | 2024-12-14T09:38:23Z |
publishDate | 2019-11-01 |
publisher | BMC |
record_format | Article |
series | BMC Anesthesiology |
spelling | doaj.art-d6f64910b1174cd4a8495652450443772022-12-21T23:07:52ZengBMCBMC Anesthesiology1471-22532019-11-011911610.1186/s12871-019-0854-zHypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: a prospective randomized controlled trialWenjing Zhang0Mo Chen1Hongbin Li2Jia Yuan3Jingjing Li4Feixiang Wu5Yan Zhang6Department of Anesthesiology, Zhoushan HospitalDepartment of Anesthesiology, Suzhou Municipal Hospital (North District), Nanjing Medical University Affiliated Suzhou HospitalDepartment of Anesthesiology, Zhoushan HospitalDepartment of Anesthesiology, Zhoushan HospitalDepartment of Anesthesiology, Zhoushan HospitalDepartment of Anesthesiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Second Military Medical UniversityDepartment of Anesthesiology, Zhoushan HospitalAbstract Background Hypoxic preconditioning (HPC) may protect multiple organs from various injuries. We hypothesized that HPC would reduce lung injury in patients undergoing thoracoscopic lobectomy. Methods In a prospective randomized controlled trial, 70 patients undergoing elective thoracoscopic lobectomy were randomly allocated to the HPC group or the control group. Three cycles of 5-min hypoxia and 3-min ventilation applied to the nondependent lung served as the HPC intervention. The primary outcome was the PaO2/FiO2 ratio. Secondary outcomes included postoperative pulmonary complications, pulmonary function, and duration of hospital stay. Results HPC significantly increased the PaO2/FiO2 ratio compared with the control at 30 min after one-lung ventilation and 7 days after operation. Compared with the control, it also significantly improved postoperative pulmonary function and markedly reduced the postoperative hospital stay duration. No significant differences between groups were observed in the incidence of pulmonary complications or overall postoperative morbidity. Conclusions HPC improves postoperative oxygenation, enhances the recovery of pulmonary function, and reduces the duration of hospital stay in patients undergoing thoracoscopic lobectomy. Trial registration This study was registered in the Chinese Clinical Trial Registry (ChiCTR-IPR-17011249) on April 27, 2017.http://link.springer.com/article/10.1186/s12871-019-0854-zHypoxic preconditioningOne-lung ventilationPaO2/FiO2 ratioPulmonary complicationsThoracoscopic lobectomyNon-small cell lung cancer |
spellingShingle | Wenjing Zhang Mo Chen Hongbin Li Jia Yuan Jingjing Li Feixiang Wu Yan Zhang Hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: a prospective randomized controlled trial BMC Anesthesiology Hypoxic preconditioning One-lung ventilation PaO2/FiO2 ratio Pulmonary complications Thoracoscopic lobectomy Non-small cell lung cancer |
title | Hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: a prospective randomized controlled trial |
title_full | Hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: a prospective randomized controlled trial |
title_fullStr | Hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: a prospective randomized controlled trial |
title_full_unstemmed | Hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: a prospective randomized controlled trial |
title_short | Hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer: a prospective randomized controlled trial |
title_sort | hypoxia preconditioning attenuates lung injury after thoracoscopic lobectomy in patients with lung cancer a prospective randomized controlled trial |
topic | Hypoxic preconditioning One-lung ventilation PaO2/FiO2 ratio Pulmonary complications Thoracoscopic lobectomy Non-small cell lung cancer |
url | http://link.springer.com/article/10.1186/s12871-019-0854-z |
work_keys_str_mv | AT wenjingzhang hypoxiapreconditioningattenuateslunginjuryafterthoracoscopiclobectomyinpatientswithlungcanceraprospectiverandomizedcontrolledtrial AT mochen hypoxiapreconditioningattenuateslunginjuryafterthoracoscopiclobectomyinpatientswithlungcanceraprospectiverandomizedcontrolledtrial AT hongbinli hypoxiapreconditioningattenuateslunginjuryafterthoracoscopiclobectomyinpatientswithlungcanceraprospectiverandomizedcontrolledtrial AT jiayuan hypoxiapreconditioningattenuateslunginjuryafterthoracoscopiclobectomyinpatientswithlungcanceraprospectiverandomizedcontrolledtrial AT jingjingli hypoxiapreconditioningattenuateslunginjuryafterthoracoscopiclobectomyinpatientswithlungcanceraprospectiverandomizedcontrolledtrial AT feixiangwu hypoxiapreconditioningattenuateslunginjuryafterthoracoscopiclobectomyinpatientswithlungcanceraprospectiverandomizedcontrolledtrial AT yanzhang hypoxiapreconditioningattenuateslunginjuryafterthoracoscopiclobectomyinpatientswithlungcanceraprospectiverandomizedcontrolledtrial |